Protalix BioTherapeutics Inc (AMEX:PLX) traded at $2.23 at close of the session on Monday, January 27 and made a downward move of -9.35% on its previous day’s price.
Looking at the stock we see that its previous close was $2.46 and the beta (5Y monthly) reads 0.672 with the day’s price range being $2.1802 – $2.44. In terms of its 52-week price range, PLX has a high of $2.54 and a low of $0.82. The company’s stock has gained about 28.90% over that past 30 days.
Protalix BioTherapeutics Inc has a market cap of $164.20 million and is expected to release its quarterly earnings report in February.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 18.21M, with a low of 18.21M and a high of 18.21M. The median projection represents growth squeezing down to 73.62% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 53.39M, or -18.49% down from figures reported last year.
On the other hand, looking at the outlook for the PLX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Looking further, we note the current price level is 2.91% off its SMA20 and 19.51% from its 50-day simple moving average. The RSI (14) is pointing at 57.49 while the volatility over the past week is 6.96% and jumps to 5.87% over the past one month. The beta value is 0.77, while the average true range (ATR) is currently pointing at 0.12.
Coming back to Protalix BioTherapeutics Inc (AMEX:PLX), we note that the average 3-month trading volume was 490.02K, while that of the preceding 10-day period stands at 0.55 million. Current shares outstanding are 73.63 million.
The insiders hold 7.56% of the company’s shares while institutions hold 5.57%. The data shows that short shares as of 2024-10-31, stood at 3.1 million at a short ratio of 22.71. This represents a 441.00 short interest in shares outstanding on 2024-10-31. Shares short fall in October from the previous month at 3.13 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 18.62% up in year-to-date price movement.
